Vera Pravica Selected Research

Vera Pravica Research Topics

Disease

4	Disease Susceptibility (Diathesis) 01/2018 - 04/2012
4	Inflammation (Inflammations) 01/2016 - 04/2005
3	Multiple Sclerosis 02/2013 - 01/2003
2	Infections 01/2021 - 02/2006
2	Delayed Graft Function 01/2018 - 04/2005
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2014 - 01/2014
2	HTLV-I Infections (HTLV-I Infection) 06/2007 - 08/2004
2	Sudden Infant Death (SID) 08/2006 - 09/2004
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2005 - 10/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Crohn Disease (Crohn's Disease) 01/2016
1	Primary Immunodeficiency Diseases 01/2016
1	Ulcerative Colitis 01/2016
1	Splenomegaly 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Common Variable Immunodeficiency 01/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2015
1	Diabetes Complications 04/2014
1	Diabetic Neuropathies (Diabetic Neuropathy) 10/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2010
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2010
1	Neoplasms (Cancer) 12/2006
1	Hepatitis C 02/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2005
1	Coronary Disease (Coronary Heart Disease) 01/2005
1	Atrial Fibrillation 01/2005
1	Atopic Dermatitis (Atopic Eczema) 09/2003
1	Fibrosis (Cirrhosis) 02/2003
1	Cystic Fibrosis (Mucoviscidosis) 02/2003
1	Portal Hypertension 02/2003
1	Demyelinating Diseases (Demyelinating Disease) 01/2003
1	Multiple Organ Failure (MODS) 10/2002
1	Hypertension (High Blood Pressure) 05/2002
1	Necrosis 05/2002
1	Essential Hypertension 05/2002
1	Melanoma (Melanoma, Malignant) 02/2002
1	Carcinogenesis 02/2002

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 01/2018 - 05/2002
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 05/2002
5	Interleukin-10 (Interleukin 10)IBA 01/2016 - 10/2002
5	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2006 - 05/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2010 - 08/2006
4	DNA (Deoxyribonucleic Acid)IBA 02/2006 - 02/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2016 - 01/2005
3	Interferon-gamma (Interferon, gamma)IBA 04/2015 - 05/2002
2	Epidermal Growth Factor (EGF)IBA 05/2002 - 02/2002
1	AntibodiesIBA 01/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018
1	Interleukin-12 (IL 12)IBA 04/2015
1	InterleukinsIBA 04/2015
1	Interleukin-23 (Interleukin 23)IBA 04/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2014
1	Biomarkers (Surrogate Marker)IBA 04/2012
1	A-factor (Streptomyces)IBA 09/2010
1	HLA-DR Antigens (HLA-DR)IBA 11/2009
1	HLA-DRB1 Chains (HLA DRB1)IBA 06/2007
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2006
1	Interleukin-4 (Interleukin 4)IBA 08/2006
1	Platelet-Derived Growth FactorIBA 02/2006
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2005
1	PerforinIBA 08/2004
1	Genetic Markers (Genetic Marker)IBA 09/2003
1	AllergensIBA 09/2003
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2003
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2003
1	Neuroprotective AgentsIBA 01/2003
1	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2002
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2002
1	5' Untranslated Regions (5' UTR)IBA 02/2002

Therapy/Procedure

2	Transplantation 01/2018 - 12/2006
1	Therapeutics 02/2013
1	Liver Transplantation 02/2006
1	Length of Stay 01/2005